Improved diagnostics and prognostics of lung cancer and metastases to the lungs
31 – 40 of 87
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
PD‐L1 Expression in Non‐Small Cell Lung Cancer Specimens : Association with Clinicopathological Factors and Molecular Alterations
- Contribution to journal › Article
-
Mark
Genome-wide interaction analysis identified low-frequency variants with sex disparity in lung cancer risk
- Contribution to journal › Article
- 2021
-
Mark
Causal relationships between body mass index, smoking and lung cancer : Univariable and multivariable Mendelian randomization
- Contribution to journal › Article
-
Mark
Comprehensive functional annotation of susceptibility variants identifies genetic heterogeneity between lung adenocarcinoma and squamous cell carcinoma
- Contribution to journal › Article
-
Mark
PD-L1 Testing in Cytological Non-Small Cell Lung Cancer Specimens : A Comparison with Biopsies and Review of the Literature
- Contribution to journal › Article
-
Mark
Integration of multiomic annotation data to prioritize and characterize inflammation and immune-related risk variants in squamous cell lung cancer
- Contribution to journal › Article
-
Mark
TGF-β-mediated epithelial–mesenchymal transition and tumor-promoting effects in CMT64 cells are reflected in the transcriptomic signature of human lung adenocarcinoma
- Contribution to journal › Article
-
Mark
Real-world diagnostic accuracy and use of immunohistochemical markers in lung cancer diagnostics
- Contribution to journal › Article
-
Mark
A gene expression-based single sample predictor of lung adenocarcinoma molecular subtype and prognosis
- Contribution to journal › Article
-
Mark
Distinct types of plexiform lesions identified by synchrotron-based phase-contrast micro-CT
- Contribution to journal › Article
